UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 127

Sortiert nach

Effects of buprenorphine on responses to social stimuli in healthy adults

Psychoneuroendocrinology, 2016-01, Vol.63, p.43-49

2016

Link zum Volltext

Verfügbarkeit prüfen

CSF opening pressure in children with optic nerve head edema

Neurology, 2011-05, Vol.76 (19), p.1658

2011

Link zum Volltext

Verfügbarkeit prüfen

Social stress and escalated drug self-administration in mice I. Alcohol and corticosterone

Psychopharmacology, 2015-03, Vol.232 (6), p.991-1001

2015

Link zum Volltext

Verfügbarkeit prüfen

Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial

Current Alzheimer research, 2008-02, Vol.5 (1), p.83

2008

Link zum Volltext

Verfügbarkeit prüfen

Rotigotine improves restless legs syndrome: A 6-month randomized, double-blind, placebo-controlled trial in the United States

Movement disorders, 2010-08, Vol.25 (11), p.1675-1683

2010

Link zum Volltext

Verfügbarkeit prüfen

Patient Position During Lumbar Puncture Has No Meaningful Effect on Cerebrospinal Fluid Opening Pressure in Children

Journal of child neurology, 2010-05, Vol.25 (5), p.616-619

2010

Link zum Volltext

Verfügbarkeit prüfen

Electrophysiological Changes in Children with Learning and Attentional Abnormalities as a Function of Age: Event-Related Potentials to an “Oddball” Paradigm

Clinical EEG electroencephalography, 1998-10, Vol.29 (4), p.188-193

1998

Link zum Volltext

Verfügbarkeit prüfen

Event-Related Potentials to an “Oddball” Auditory Paradigm in Children with Learning Disabilities with or without Attention Deficit Hyperactivity Disorder

Clinical EEG electroencephalography, 1994-10, Vol.25 (4), p.136-141

1994

Link zum Volltext

Verfügbarkeit prüfen

The importance of drug titration in the management of patients with epilepsy

Epilepsy & behavior, 2022-03, Vol.128, p.108517-108517, Article 108517

2022

Link zum Volltext

Verfügbarkeit prüfen

Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat

The Journal of neuroscience, 1998-07, Vol.18 (13), p.5086-5094

1998

Link zum Volltext

Verfügbarkeit prüfen

An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomnia

Sleep medicine, 2006, Vol.7 (1), p.17-24

2006

Link zum Volltext

Verfügbarkeit prüfen

Practice Parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

Neurology, 2007-11, Vol.69 (21), p.1996

2007

Link zum Volltext

Verfügbarkeit prüfen

A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity

Journal of psychopharmacology (Oxford), 2018-06, Vol.32 (6), p.668-677

2018

Link zum Volltext

Verfügbarkeit prüfen

Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations

Neurology and therapy, 2022-12, Vol.11 (4), p.1705-1720

2022

Link zum Volltext

Verfügbarkeit prüfen

Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule

Neuroscience and biobehavioral reviews, 2005, Vol.29 (4), p.785-798

2005

Link zum Volltext

Verfügbarkeit prüfen

Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers

Sleep medicine, 2022-12, Vol.100, p.442-447

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia

Sleep (New York, N.Y.), 2007-11, Vol.30 (11), p.1555-1561

2007

Link zum Volltext

Verfügbarkeit prüfen

Response to: Once-nightly sodium oxybate (FT218) in the treatment of narcolepsy: a letter to the editor commenting on the recent publication by C. Kushida et al

Sleep (New York, N.Y.), 2022-06, Vol.45 (6), p.1

2022

Link zum Volltext

Verfügbarkeit prüfen

Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy

Sleep (New York, N.Y.), 2022-06, Vol.45 (6), p.1

2022

Link zum Volltext

Verfügbarkeit prüfen

Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia

Sleep medicine, 2006-06, Vol.7 (4), p.312-318

2006

Link zum Volltext

Verfügbarkeit prüfen

Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial

CNS drugs, 2022-04, Vol.36 (4), p.377-387

2022

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double-blind, single-dose, placebo-controlled, multicenter, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance

Journal of clinical sleep medicine, 2014-10, Vol.10 (10), p.1093-1100

2014

Link zum Volltext

Verfügbarkeit prüfen

APD125, a Selective Serotonin 5-HT2A Receptor Inverse Agonist, Significantly Improves Sleep Maintenance in Primary Insomnia

Sleep (New York, N.Y.), 2008-12, Vol.31 (12), p.1663-1671

2008

Link zum Volltext

Verfügbarkeit prüfen

A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia

Sleep (New York, N.Y.), 2005-06, Vol.28 (6), p.720-727

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 127

Suche als RSS-Feed

Aktive Filter

ThemaNeurosciences & Neurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(119)

Publikationsform

Artikel
(127)

Sprache

Englisch
(127)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of buprenorphine on responses to social stimuli in healthy adults

CSF opening pressure in children with optic nerve head edema

Social stress and escalated drug self-administration in mice I. Alcohol and corticosterone

Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial

Rotigotine improves restless legs syndrome: A 6-month randomized, double-blind, placebo-controlled trial in the United States

Patient Position During Lumbar Puncture Has No Meaningful Effect on Cerebrospinal Fluid Opening Pressure in Children

Electrophysiological Changes in Children with Learning and Attentional Abnormalities as a Function of Age: Event-Related Potentials to an “Oddball” Paradigm

Event-Related Potentials to an “Oddball” Auditory Paradigm in Children with Learning Disabilities with or without Attention Deficit Hyperactivity Disorder

The importance of drug titration in the management of patients with epilepsy

Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat

An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomnia

Practice Parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity

Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations

Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule

Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers

Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia

Response to: Once-nightly sodium oxybate (FT218) in the treatment of narcolepsy: a letter to the editor commenting on the recent publication by C. Kushida et al

Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy

Biomarkers of Coagulation and Inflammation in COVID-19–Associated Ischemic Stroke

Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia

Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial

A randomized, double-blind, single-dose, placebo-controlled, multicenter, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance

APD125, a Selective Serotonin 5-HT2A Receptor Inverse Agonist, Significantly Improves Sleep Maintenance in Primary Insomnia

A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia

Aktive Filter

Suchergebnisse filtern